RyCarma Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch RyCarma Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Trial to Compare Treatment With Surlorian (ARM210, S48168) to Placebo in Effects on Muscle Strength and Safety in Adults With Autosomal Dominant RYR1-related Myopathy (NCT07560020) | RyCarma Therapeutics, Inc. | 2026-07-01 |
| Treatment of an Inherited Ventricular Arrhythmia (NCT05122975) | RyCarma Therapeutics, Inc. | 2023-08-01 |
| S 48168 (ARM 210) for the Treatment of RYR1-related Myopathies (RYR1-RM) (NCT04141670) | RyCarma Therapeutics, Inc. | 2020-08-25 |
Track RyCarma Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.